Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Retrovirus from the HIV group and its use

Retrovirus from the HIV group and its use

US Patent 6551824 · Granted Apr 22, 2003

Estimated economic value: $6,687,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Coagulation factor X polypeptides with modified activation properties2016
Coagulation factor X polypeptides with modified activation properties2016
Modified vitamin K dependent polypeptides2014
Antigenic HIV gp41 chimeric polypeptides comprising the MVP5180/91 epitope SKGKL2010
Antigenic HIV gp41 chimeric polypeptides comprising the MVP5180/91 epitope SKGKL2010
Human procalcitonin and the preparation and use thereof2008
Use of plasma proteins concentrates containing VWF with a high proportion of hig2008
Varicella zoster virus (VZV) immunoreactive protein VP26 and its diagnostic use2006
Retrovirus from the HIV type O and its use (MVP-2901/94)2005
Retrovirus from the HIV type O and its use (MVP-2901/94)2005
Retrovirus from the HIV type O and its use (MVP-2901/94)2005
Immunoreactive regions of glycoprotein gpII of varicella zoster virus (VZV)2005